Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Kamada stock

Learn how to easily invest in Kamada stock.

- $0.06 ( - 1.33%)

Kamada is a drug manufacturers-specialty & generic business based in the US. Kamada shares (KMDA) are listed on the NASDAQ and all prices are listed in US Dollars. Kamada employs 355 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Kamada

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KMDA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Kamada stock price (NASDAQ: KMDA)

Use our graph to track the performance of KMDA stocks over time.

Kamada shares at a glance

Information last updated 2022-07-01.
Latest market close$4.45
52-week range$4.22 - $6.96
50-day moving average $4.77
200-day moving average $5.62
Wall St. target price$11.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.15

Buy Kamada shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kamada stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kamada price performance over time

Historical closes compared with the close of $4.45 from 2022-07-01

1 week (2022-06-24) -3.47%
1 month (2022-06-03) -4.30%
3 months (2022-04-04) -20.39%
6 months (2022-01-04) -31.75%
1 year (2021-07-02) -24.06%
2 years (2020-07-02) -49.60%
3 years (2019-07-03) 5.56
5 years (2017-07-03) 5.95

Is Kamada stock undervalued or overvalued?

Valuing Kamada stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Kamada's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Kamada's PEG ratio

Kamada's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 8.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Kamada's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Kamada's EBITDA

Kamada's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.4 million.

The EBITDA is a measure of a Kamada's overall financial performance and is widely used to measure a its profitability.

Kamada financials

Revenue TTM $106.8 million
Gross profit TTM $30.3 million
Return on assets TTM -0.25%
Return on equity TTM -3.79%
Profit margin -6.31%
Book value $3.83
Market capitalisation $202.1 million

TTM: trailing 12 months

Kamada share dividends

We're not expecting Kamada to pay a dividend over the next 12 months.

Kamada share price volatility

Over the last 12 months, Kamada's shares have ranged in value from as little as $4.22 up to $6.96. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kamada's is 0.2339. This would suggest that Kamada's shares are less volatile than average (for this exchange).

Kamada overview

Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis ; and ELIGARD for prostate cancer.

Frequently asked questions

What percentage of Kamada is owned by insiders or institutions?
Currently 28.967% of Kamada shares are held by insiders and 32.718% by institutions.
How many people work for Kamada?
Latest data suggests 355 work at Kamada.
When does the fiscal year end for Kamada?
Kamada's fiscal year ends in December.
Where is Kamada based?
Kamada's address is: 2 Holzman Street, Rehovot, Israel, 7670402
What is Kamada's ISIN number?
Kamada's international securities identification number is: IL0010941198
What is Kamada's CUSIP number?
Kamada's Committee on Uniform Securities Identification Procedures number is: M6240T109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site